HomeNDC LookupIngredientsMiconazole Nitrate › 00536-1375-75
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g Cream, 1 tube — NDC 00536-1375-75 package photo

MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g Cream, 1 tube

by Rugby · 1 TUBE in 1 BOX (0536-1375-75) / 28.3 g in 1 TUBE
NDC 00536-1375-75
🏷️ FDA NDC (as labeled) 0536-1375-75 billing pads the labeler segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Miconazole Nitrate (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Jan 10, 2024 — Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list. (MEDLINE INDUSTRIES, LP - Northfield) · FDA recall D-0315-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 0536-1375-75
Product NDC 0536-1375
11-digit billing NDC 00536137575
NCPDP billing unit GM — per gram (weight)
RxCUI 998483
UNII VW4H1CYW1K
UPC 0305361375751
Application # M005
SPL Set ID f420de00-408f-9a2c-e053-2995a90adced
Established class (EPC) Azole Antifungal
Chemical class Azoles
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2023-02-07
Route TOPICAL
Dosage form CREAM
Substance MICONAZOLE NITRATE
GPI-14 90154050103705
GCN Seq No 007366
GCN 30400
HICL code 003031
Ingredient (HICL) Miconazole Nitrate
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.08
AHFS class Azoles (Skin And Mucous Membrane)
FDB label name MICONAZOLE 2% TOPICAL CREAM
FDB brand name Miconazole Nitrate
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0536-1375-75 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00536-1375-75. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Azole Antifungal class.

Pharmacologic class Azole Antifungal
Drug family (ATC) Antiinfectives and antiseptics for local oral treatment, Imidazole derivatives, Imidazole and triazole derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerRugby
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code00536
First marketedFeb 2023
Product typeHuman Otc Drug
Portfolio2 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name MICONAZOLE 2% TOPICAL CREAM Ingredient Miconazole Nitrate
📖 What it is MedlinePlus · NLM

Topical miconazole is used to treat tinea corporis(ringworm; fungal skin infection that causes a red scaly rash on different parts of the body), tinea cruris (jock itch; fungal infection of the skin in the groin or buttocks), and tinea pedis (athlete's foot; fungal infection of the skin on the feet and between the toes). Miconazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection. Not all products should be used to treat all of these conditions. Please read the label for each product to select the one to treat your conditi...

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • For a 7-night vaginal cream, you insert one full applicator into your vagina at bedtime for 7 nights in a row. If you have itching or irritation on the outside, squeeze a small amo...
  • I bought a miconazole cream for a vaginal yeast infection — how do I use it correctly?
  • Yes — topical miconazole creams and powders are specifically made for those conditions. For athlete's foot and ringworm, you'd apply it to clean, dry skin twice a day for 4 weeks....
  • Can I use miconazole cream on my skin for athlete's foot or jock itch?
📖 Read our full Miconazole guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 0A5MM307FC
    A synthetic polymer that absorbs water and forms a thick, gel-like substance. In medicines, it works as a thickener and stabilizer to improve texture and help ingredients stay mixed together in creams, gels, and lotions.
  • UNII 2DMT128M1S
    A waxy solid derived from plant or animal sources. It acts as an emulsifier to blend oil and water components, and also thickens the medicine to give it the right texture and consistency.
  • UNII YOW8V9698H
    Dimethyl sulfoxide is a clear liquid solvent derived from wood pulp. In medicines, it helps dissolve or carry active ingredients and improve how the body absorbs the drug.
  • UNII 7FLD91C86K
    Edetate disodium is a chemical compound that binds and removes certain metal ions. In medicines, it acts as a preservative and stabilizer by preventing metals like calcium from interfering with the product's shelf life and consistency.
  • UNII 14255EXE39
    Ethylparaben is a preservative, a chemical that stops bacteria and mold from growing in the medicine. It keeps the product safe and effective throughout its shelf life.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII KC98RO82HJ
    A waxy substance made from glycerin and fatty acids. It acts as an emulsifier to help mix oil and water components, and as a thickener to give the medicine proper texture and consistency.
  • UNII W9D845551A
    Laureth-30 is a synthetic surfactant made from lauryl alcohol and ethylene oxide. It helps dissolve, mix, and stabilize oil and water components in liquid medicines, acting as an emulsifier and solubilizer.
  • UNII T5L8T28FGP
    Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
  • UNII 4ELV7Z65AP
    Stearic acid is a fatty acid derived from plant or animal sources. It acts as a binder and lubricant in tablets and capsules, helping them hold together and flow smoothly during manufacturing.
  • UNII 9O3K93S3TK
    Trolamine is an alkaline compound used as a pH buffer and emulsifier in medicines. It helps neutralize acids, stabilize formulations, and enable mixing of oil and water-based ingredients.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

14 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients Carbomer, alcohol, cetostearyl alcohol, dimethyl sulfoxide, edetate disodium, ethylparaben, glycerol, mineral oil, mono and di glycerides, polyoxyethylene lauryl ether, purified water, stearic acid, triethanolamine, petrolatum.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.120 $3.38 / 28.3 g
Medicaid paysCMS SDUD · 12 mo $0.2349 $6.65 / 28.3 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2023 Dec 2025 Apr 2026 Aug 2026 $0.143 $0.116
▼ Down 17% over the last 12 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Antifungal Cream 2 g/100g 21922-0095-06 Encube 1 tube $0.080 Availability likely save 33%
Antifungal Cream 2 g/100g 68001-0481-45 BluePoint 1 tube $0.083 Availability likely save 31%
Miconazole Nitrate Cream USP, 2% 2 g/100g 70000-0340-01 Cardinal 28.4 g $0.083 Availability likely save 31%
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100gthis 00536-1375-75 Rugby 1 tube $0.119 Availability likely
Miconazole Nitrate 20 mg/g 70677-1000-01 STRATEGIC 1 tube $0.119 Availability likely
SUNMARK MICONAZOLE NITRATE antifungal 20 mg/g 49348-0689-72 Strategic 1 tube $0.122 Availability likely +2%
Miconazole Nitrate 20 mg/g 51672-2001-01 Sun 1 tube $0.203 Availability likely +70%
Selan Antifungal 2 g/100g 00159-2500-04 Trividia 117 g FDA listed
Desenex Antifungal Foot Cream 20 mg/g 00316-0255-01 Crown 1 tube FDA listed
Baza Antifungal 20 mg/g 11701-0045-14 Coloplast 142 g FDA listed
MacerRx Web 2 g/100g 44577-0205-56 Clinical 1 tube FDA listed
Miconazole Nitrate 20 mg/g 50090-1071-00 A-S 1 tube FDA listed
Miconazole Nitrate 20 mg/g 50090-5607-00 A-S 1 tube FDA listed
Miconazole Nitrate 20 mg/g 50090-5674-00 A-S 1 tube FDA listed
Miconazole Nitrate 20 mg/g 50090-7364-00 A-S 1 tube FDA listed
CAREALL Miconazole Nitrate 20 mg/g 51824-0078-01 New 28 g FDA listed
Anti-Fungal .02 g/g 52000-0021-37 Universal 1 tube FDA listed
Medline 20 mg/mL 53329-0147-44 Medline 118 ml FDA listed
Remedy Antifungal With Olivamine 2 g/100g 53329-0162-04 Medline 113 g Discontinued
Medline 20 mg/100g 53329-0218-44 Medline 113 g FDA listed
ProCure Antifungal Cream 2 g/100g 55681-0023-04 Twin 106 g FDA listed
ProCure Antifungal 2 g/100g 55681-0047-04 Twin 106 g FDA listed
Lasolex AC 2 g/100g 59088-0239-07 PureTek 85 g FDA listed
Conazol 20 mg/g 59208-0001-30 Laboratorios 30 g FDA listed
Private Label Antifungal Barrier Cream 20 g/1000g 60232-0009-02 Swiss-American 60 g FDA listed
BOA VIDA Antifungal 2 g/100g 62654-0147-01 Central 113 g FDA listed
Micatin 20 mg/g 65197-0103-05 WellSpring 14 g FDA listed
Antifungal 2 g/100g 67777-0710-02 Dynarex 144 packets FDA listed
Miconazole 20 mg/g 68016-0291-01 Chain 1 tube FDA listed
MICONAZOLE Nitrate 2 g/100g 68071-3429-03 NuCare 1 tube FDA listed
Antifungal Body 2 mg/100mL 68599-0206-04 McKesson 118 ml FDA listed
Miconazole Nitrate 2 mg/100mg 68599-1471-04 McKesson 118 mg FDA listed
Antifungal Cream 2 g/100g 68788-8645-02 Preferred 1 tube FDA listed
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 68788-8845-03 Preferred 1 tube FDA listed
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 68788-8895-03 Preferred 1 tube FDA listed
PiYanPing Antifungal 2 g/100g 69070-0304-01 Zhejiang 1 tube FDA listed
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 69396-0014-05 Trifecta 15 g FDA listed
FifthPulse Miconazole Nitrate Cream 1oz 20 mg/g 69571-0016-01 Front 28.4 g FDA listed
FifthPulse Miconazole Nitrate Cream 4oz 2 g/100g 69571-0017-01 Front 113.4 g FDA listed
Secura Antifungal Greaseless 20 mg/g 69740-0328-00 Smith 57 g FDA listed
Secura Antifungal Extra Thick 20 mg/g 69740-0329-00 Smith 92 g FDA listed
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 69771-0041-25 GERI-GENTLE 113 g FDA listed
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 70000-0718-01 Cardinal 1 tube FDA listed
MICONAZOLE Nitrate 2% 2 g/100g 71399-0071-01 Akron 1 tube FDA listed
MICONAZOLE Nitrate 2% Cream ANTIFUNGAL 2 g/100g 77338-0041-25 ASTONEA 113 g FDA listed
Athletes Foot 2 g/100mL 83004-0014-01 Rida 1 bottle FDA listed
Fungazol Athlete Foot 2 g/100mL 83004-0025-01 Rida 1 bottle FDA listed
Pharmlitalia Jock Itch Miconazole Nitrate 2 g/100mL 83004-0031-01 Rida 1 jar FDA listed
ElixirTripleGuard Triple Antibiotic 2 g/100g 84546-0007-01 ELIXIR 113 g FDA listed
Hermon Jock Itch Ringworm and athlete s foot cream 2 g/100g 84746-0008-01 Shandong 100 g Discontinued
Nedtol Folliculitis Treatment Creams 2 g/100g 84867-0022-01 Jiashen 120 g FDA listed
Beilloso Balanitis Relief 2 g/100mL 85248-0138-01 Jiangxi 30 ml FDA listed
Inlifay ANTIFUNGAL 2 g/100g 85248-0139-01 Jiangxi 100 g FDA listed
Charmpoo Antifungal Cream 2 g/100g 85248-0142-01 Jiangxi 100 g FDA listed
Charmpoo Antifungal Cream 2 g/100g 85248-0212-01 Jiangxi 30 g FDA listed
Charmpoo Antifungal Cream 2 g/100g 85248-0226-01 Jiangxi 2 tubes FDA listed
BODYKOO ATHLETE FOOT Cream 2 g/100g 85248-0229-01 Jiangxi 30 g FDA listed
Tagrid Jock Itch Miconazole Nitrate 2% 20 mg/g 85384-0003-01 TAGRID 100 g FDA listed
Ringworm Treatment Cream 2 g/100g 85398-0024-01 Beautivity 100 g FDA listed
Hermon Jock Itch Antifungal Treatment Cream 1.2 g/60g 85398-0032-01 Beautivity 60 g FDA listed
RoyceDerm Tinea Antifungal Cream 20 mg/g 85424-0011-01 RoyceDerm 57 g FDA listed
RoyceDerm Anti-Fungal Cream 2 g/100g 85424-0021-01 RoyceDerm 100 g FDA listed
Aosorw Antifungal Cream 2 g/100g 85498-0011-01 SpineStatus 120 g FDA listed
Kerova Miconazole Nitrate 2 g/100g 85959-0001-01 Guangzhou 100 g FDA listed
Recuren Plus Antifungal Cream 20 mg/g 87014-0001-01 REGENEREN 100 g FDA listed
Recuren Plus Jock Itch Cream 20 mg/g 87014-0004-01 REGENEREN 30 g FDA listed
Kopa Haiku Antifungal Cream 20 mg/g 87041-0001-01 Trovina 100 g FDA listed
Kopa Haiku Antifungal Cream 20 mg/g 87041-0002-01 Trovina 30 g FDA listed
Kopa Haiku Antifungal Cream 20 mg/g 87041-0004-01 Trovina 60 g FDA listed
Kopa Haiku Ringworm Treatment Cream 20 mg/g 87041-0008-01 Trovina 30 g FDA listed
Miconazole Cream 2 g/100g 87236-0013-04 Aldermed 113 g FDA listed
Doctor Jiao Antifungal Cream 2 g/100g 87537-0002-02 Jiangxi 1 tube FDA listed
Lasolex AG 2 g/100g 59088-0207-07 Puretek 85 g FDA listed
Femmesil Maximum Strength 2 g/100g 24909-0202-28 Aidance 1 bottle Discontinued
White Tetterine 2 g/100g 12258-0242-01 S.S.S. 1 tube FDA listed
Triple Antifungal 2 g/100g 16864-0040-02 Advantice 1 tube FDA listed
Green Tetterine 2 g/100g 12258-0241-01 S.S.S. 1 can FDA listed
Claravie 2 g/100g 61554-0305-11 Gentell 113 g FDA listed
MOROVANJock Itch Antifungal 2 g/100g 87800-0006-01 HONG 100 g FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2023
On the market since
Feb 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00536-1375-75, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
13.4K
Units reimbursed last 4 qtrs
510.8K
Gross reimbursed last 4 qtrs
$120K
Avg / prescription
$8.98
Avg / unit
$0.2349
Latest quarter Q4 2025
5KRx
Medicaid pays / g
$0.2349
gross reimbursed
vs
NADAC / g
$0.1195
acquisition cost
=
Spread
+$0.1154
+97% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
53% FFS 47% MCO
Fee-for-service · 7,051 Rx Managed care · 6,311 Rx
State Medicaid map
Alaska: no data reported AK Maine: 4,920 units · 353 per 100k residents ME Washington: 35,748 units · 458 per 100k residents WA Idaho: 840 units · 42.8 per 100k residents ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 16,159 units · 282 per 100k residents MN Wisconsin: 14,004 units · 237 per 100k residents WI Michigan: 15,166 units · 151 per 100k residents MI New York: 65,572 units · 335 per 100k residents NY Vermont: 718 units · 111 per 100k residents VT New Hampshire: 2,008 units · 143 per 100k residents NH Oregon: 9,065 units · 214 per 100k residents OR Nevada: 1,830 units · 57.3 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: 7,374 units · 230 per 100k residents IA Illinois: 24,565 units · 196 per 100k residents IL Indiana: 20,496 units · 299 per 100k residents IN Ohio: 29,190 units · 248 per 100k residents OH Pennsylvania: 20,042 units · 155 per 100k residents PA New Jersey: 7,495 units · 80.7 per 100k residents NJ Massachusetts: 18,358 units · 262 per 100k residents MA California: 113,028 units · 290 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: 6,739 units · 341 per 100k residents NE Missouri: 10,515 units · 170 per 100k residents MO Kentucky: 11,869 units · 262 per 100k residents KY West Virginia: 2,310 units · 131 per 100k residents WV Virginia: 8,606 units · 98.7 per 100k residents VA Maryland: 4,830 units · 78.2 per 100k residents MD Connecticut: 8,970 units · 248 per 100k residents CT Rhode Island: 4,571 units · 417 per 100k residents RI Arizona: 12,543 units · 169 per 100k residents AZ New Mexico: 480 units · 22.7 per 100k residents NM Kansas: 9,247 units · 315 per 100k residents KS Arkansas: no data reported AR Tennessee: 3,240 units · 45.5 per 100k residents TN North Carolina: no data reported NC South Carolina: 2,010 units · 37.4 per 100k residents SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 360 units · 12.2 per 100k residents MS Alabama: no data reported AL Georgia: 3,600 units · 32.6 per 100k residents GA D.C.: no data reported DC Hawaii: 990 units · 69.0 per 100k residents HI Texas: 13,017 units · 42.7 per 100k residents TX Florida: 330 units · 1.5 per 100k residents FL
Units reimbursed · per 100k residents
1.5458
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Washington 458 /100k
2 Rhode Island 417 /100k
3 Maine 353 /100k
4 Nebraska 341 /100k
5 New York 335 /100k
6 Kansas 315 /100k
7 Indiana 299 /100k
8 California 290 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Miconazole 3 (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Miconazole 3. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$35.6K
Claims incl. refills
725
Beneficiaries
649
Spend / beneficiary
$54.91
Spend / claim
$49.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for MICONAZOLE Nitrate 2% Cream ANTIFUNGAL (this brand).

Top reported reactions

Vulvovaginal Burning Sensation242
Vulvovaginal Pain79
Vulvovaginal Pruritus73
Condition Aggravated72
Drug Interaction58
Vulvovaginal Discomfort47
Vaginal Haemorrhage42

Age at onset

Neonate1
Infant3
Child3
Adolescent2
Adult79
Elderly62

Reporter sex

1,346 reports
Male · 23%
Female · 76%
Unknown · 0%
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 141 94
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
00536-1375-75 You're viewing this 1 TUBE in 1 BOX (0536-1375-75) / 28.3 g in 1 TUBE 2023-02-07 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 32 words

Uses proven clinically effective in the treatment of most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) relieves itching, scaling, cracking, burning and discomfort associated with these conditions.

⏱️ Dosage and Administration 116 words

Directions Clean the affected area and dry thoroughly • Apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a healthcare professional • Supervise children in the use of this product. For athlete's foot: • Use daily for 4 weeks. If condition persists, consult a doctor • Pay special attention to the spaces between the toes • Wear well fitting, ventilated shoes • Change socks at least once daily.

For ringworm: Use daily for 4 weeks. If condition persists, consult a doctor. For jock itch: Use daily for 2 weeks.

If condition persists longer, consult a doctor. This product is not effective on the scalp or nails.

⚠️ Warnings 79 words

Warnings For external use only. Do not use if the safety-sealed tube is punctured or damaged. Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with the eyes. Stop use and ask a doctor if • irritation occurs or if there is no improvement within 4 weeks (for athlete's foot and ringworm) • Irritation occurs, or if there is no improvement within 2 weeks (for jock itch).

📦 Storage and Handling 35 words

Other Information • Store at 15° - 30° c (59° - 86° f) • Lot number and expiration date see crimp of tube or see box. • To open: Unscrew cap, tear safety seal off.

🧪 Active Ingredient 5 words

Active ingredient Miconazole Nitrate 2%

🧪 Inactive Ingredients 27 words

Inactive ingredients Carbomer, alcohol, cetostearyl alcohol, dimethyl sulfoxide, edetate disodium, ethylparaben, glycerol, mineral oil, mono and di glycerides, polyoxyethylene lauryl ether, purified water, stearic acid, triethanolamine, petrolatum.

🎯 Purpose 2 words

Purpose Anti-Fungal

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.